BRBR
BellRing Brands, Inc. · Consumer Staples · Packaged Foods
Last
$18.41
−$0.43 (−2.31%) 4:00 PM ET
After hours $18.39 −$0.02 (−0.08%) 8:56 PM ET
Prev close $18.84
Open $18.79
Day high $18.79
Day low $17.81
Volume 2,692,729
Avg vol 4,405,709
Mkt cap
$2.16B
P/E ratio
12.78
FY Revenue
$2.32B
EPS
1.44
Gross Margin
31.52%
Sector
Consumer Staples
AI report sections
BRBR
BellRing Brands, Inc.
No AI report section text found yet for this symbol.
AI summarized at 1:08 AM ET, 2025-04-13
Volume vs average
Intraday (cumulative)
−6% (Below avg)
Vol/Avg: 0.94×
RSI
38.29 (Weak)
Weak (30–40)
MACD momentum
Intraday
+0.00 (Strong)
MACD: 0.01 Signal: 0.00
Short-Term
+0.22 (Strong)
MACD: -1.74 Signal: -1.96
Long-Term
+0.02 (Strong)
MACD: -3.21 Signal: -3.23
Intraday trend score 57.00

Latest news

BRBR 12 articles Positive: 0 Neutral: 0 Negative: 12
Negative GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
Bronstein, Gewirtz & Grossman LLC Urges BellRing Brands, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against BellRing Brands, Inc. alleging that the company made materially false statements about its sales performance. The complaint claims BellRing failed to disclose that strong sales results were driven by customer inventory accumulation due to past supply shortages, rather than genuine demand, and that once inventory concerns eased, customers reduced orders. The company later admitted to weakening demand from competitive pressures.

BRBR class action lawsuit securities fraud BellRing Brands investor harm false statements inventory destocking competitive pressures
Sentiment note

The company is accused of making materially false and misleading statements regarding sales performance, failing to disclose that strong results were artificially inflated by customer inventory buildup rather than genuine demand. The lawsuit alleges deceptive practices that harmed investors during the Class Period (November 19, 2024 - August 4, 2025).

Negative GlobeNewswire Inc. • Rosen Law Firm
BRBR DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages BellRing Brands, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BRBR

Rosen Law Firm announces a March 23, 2026 deadline for investors to join a securities class action against BellRing Brands, Inc. The lawsuit alleges that BellRing misrepresented sales growth during the Class Period (November 19, 2024 - August 4, 2025), claiming organic growth and strong demand when sales were actually driven by customer inventory stockpiling. The company allegedly downplayed competitive pressures while possessing a purported 'competitive moat,' but later admitted to weakening demand following destocking.

BRBR securities class action BellRing Brands misrepresentation inventory stockpiling sales growth competitive pressures lead plaintiff deadline
Sentiment note

The company is accused of materially misrepresenting sales drivers, falsely attributing growth to organic demand and distribution gains when sales were actually driven by customer inventory stockpiling. Additionally, defendants allegedly downplayed significant competitive pressures while claiming a competitive advantage, leading to investor losses.

Negative GlobeNewswire Inc. • Hagens Berman
BellRing Brands (BRBR) Facing Securities Class Action Amid Questions About Destocking, Consumption and Competition - Hagens Berman

BellRing Brands (BRBR) faces a securities class action lawsuit alleging that executives misled investors about the true drivers of 2025 sales growth. The suit claims growth was fueled by retailers hoarding inventory due to prior supply chain concerns, rather than genuine consumer demand. When retailers began destocking excess inventory, BellRing's stock collapsed 33% in a single day on August 4, 2025. The lead plaintiff deadline is March 23, 2026.

BRBR securities fraud class action lawsuit inventory hoarding destocking misleading statements sales growth supply chain
Sentiment note

The company is accused of securities fraud and misleading investors about the sustainability of sales growth. Actual growth was allegedly driven by temporary inventory hoarding rather than genuine consumer demand, leading to a 33% stock price collapse when the truth emerged.

Negative GlobeNewswire Inc. • Claimsfiler
BellRing Brands Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against BellRing Brands, Inc. - BRBR

BellRing Brands faces a securities class action lawsuit for failing to disclose material information between November 2024 and August 2025. The company experienced significant stock price declines following disappointing guidance disclosures in May and August 2025, with shares falling 19% and 33% respectively due to retailer inventory reductions and increased competition in the protein RTD market.

BRBR class action lawsuit securities fraud material non-disclosure stock price decline retailer inventory protein RTD market lead plaintiff deadline
Sentiment note

The company is facing a securities class action lawsuit for alleged failure to disclose material information. Stock experienced severe declines of 19% and 33% following disappointing earnings guidance and retailer inventory reductions, indicating significant operational and competitive challenges in the convenient nutrition market.

Negative GlobeNewswire Inc. • Law Offices Of Howard G. Smith
DEADLINE ALERT for SDM, BRBR, METC, CLEUF: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Law Offices of Howard G. Smith has announced multiple securities fraud class action lawsuits against four publicly-traded companies: Smart Digital Group Limited (SDM), BellRing Brands Inc. (BRBR), Ramaco Resources Inc. (METC), and China Liberal Education Holdings Limited (CLEUF). The lawsuits allege that defendants made false and misleading statements regarding their business operations, market conditions, and financial prospects. Investors have until late March 2026 to file lead plaintiff motions.

SDM BRBR METC METCB securities fraud class action lawsuit false statements market manipulation
Sentiment note

Alleged false representations about sales growth and consumer demand; customers accumulated excess inventory due to supply concerns and subsequently reduced orders, indicating weakening demand masked by misleading statements.

Negative GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
Bronstein, Gewirtz & Grossman LLC Urges BellRing Brands, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against BellRing Brands, Inc. alleging that the company made materially false statements about its sales performance. The complaint claims BellRing failed to disclose that strong sales results were driven by customer inventory accumulation due to past supply shortages, rather than genuine demand, and that sales declined once customers destocked and competitive pressures intensified.

BRBR class action lawsuit securities fraud BellRing Brands false statements inventory destocking investor harm lead plaintiff deadline
Sentiment note

The company is accused of making materially false and misleading statements regarding sales performance, failing to disclose that strong results were due to customer inventory buildup rather than genuine demand, and subsequently experiencing significant sales declines due to destocking and competitive pressures. This represents alleged securities fraud causing investor harm.

Negative GlobeNewswire Inc. • Kahn Swick & Foti, Llc
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Kahn Swick & Foti, LLC has filed securities fraud class action lawsuits against uniQure N.V., Corcept Therapeutics, and BellRing Brands for allegedly failing to disclose material information to investors. uniQure's stock declined 49% after the FDA rejected data supporting its drug candidate AMT-130's accelerated approval. Similar FDA approval issues and inventory problems caused significant stock declines at the other companies. Investors have until April 13, 2026 to file lead plaintiff applications.

QURE BRBR CORT securities fraud class action lawsuit FDA approval stock decline material information disclosure
Sentiment note

Company facing securities fraud lawsuit due to undisclosed inventory issues resulting in a 52% stock decline and significant investor losses.

Negative GlobeNewswire Inc. • Kahn Swick & Foti, Llc
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Kahn Swick & Foti, LLC announced multiple securities fraud class action lawsuits against pharmaceutical and consumer companies. Corcept Therapeutics faces allegations of failing to disclose material information about its relacorilant drug candidate, which received a Complete Response Letter from the FDA instead of approval, causing a 50.4% stock decline. Similar lawsuits were filed against uniQure N.V. for FDA approval delays (49% decline) and BellRing Brands for inventory issues (52% decline). Investors have until April 21, 2026 to file lead plaintiff applications.

CORT QURE BRBR securities fraud class action lawsuit FDA approval stock decline material information disclosure
Sentiment note

Company facing securities fraud lawsuit due to inventory issues, resulting in a 52% stock decline.

Negative GlobeNewswire Inc. • Kahn Swick & Foti, Llc
BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Kahn Swick & Foti, LLC has filed securities fraud class action lawsuits against BellRing Brands, uniQure N.V., and Corcept Therapeutics for allegedly failing to disclose material information. BellRing's stock declined 52% following inventory and retailer supply issues, uniQure's stock fell 49% due to FDA approval delays, and Corcept's stock dropped 50% related to FDA approval issues. Investors have until March 23, 2026 to file lead plaintiff applications.

QURE CORT BRBR securities fraud class action lawsuit stock decline material information disclosure FDA approval
Sentiment note

Company faced 52% stock decline due to undisclosed inventory issues and retailer supply reductions. Securities fraud allegations for failing to disclose material information about retail inventory levels and revised sales guidance.

Negative GlobeNewswire Inc. • Robbins Llp
Robbins LLP Urges BRBR Investors with Large Losses in BellRing Brands, Inc. to Contact the Firm for Information About the Class Action Lawsuit

Robbins LLP has filed a class action lawsuit against BellRing Brands, Inc. (BRBR) on behalf of investors who purchased securities between November 19, 2024 and August 4, 2025. The lawsuit alleges that BellRing misled investors about its sales performance, which was driven by customer inventory accumulation rather than genuine demand. Following the company's August 4, 2025 earnings report revealing a disappointing 2025 outlook, BRBR stock plummeted 33% from $53.64 to $36.18 per share.

BRBR class action lawsuit securities fraud inventory destocking misleading guidance stock decline shareholder losses
Sentiment note

The company is accused of misleading investors about the true drivers of its sales performance, concealing that strong results were due to customer inventory buildup rather than genuine demand. The subsequent 33% stock price decline and narrowed negative guidance further support the negative sentiment.

Negative GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
Bronstein, Gewirtz & Grossman LLC Urges BellRing Brands, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against BellRing Brands, Inc. alleging that the company made materially false statements about its sales performance. The complaint claims BellRing failed to disclose that strong sales resulted from customer inventory accumulation due to past supply shortages, rather than genuine demand, and that sales declined once customers destocked and competitive pressures intensified.

BRBR class action lawsuit securities fraud BellRing Brands investor harm false statements inventory destocking competitive pressures
Sentiment note

The company is accused of making materially false and misleading statements regarding sales performance, failing to disclose that strong sales were driven by customer inventory accumulation rather than genuine demand, and subsequently experiencing significant sales declines due to destocking and competitive pressures. These allegations constitute securities fraud and investor harm.

Negative GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
BellRing Stock Notice: BellRing Brands, Inc. (NYSE:BRBR) Shares Sink 33% on Inventory Issues - Investors Notified to Contact BFA Law about Pending Securities Fraud Class Action

Bleichmar Fonti & Auld LLP filed a securities fraud class action against BellRing Brands (NYSE:BRBR) after the company's stock plummeted 33% in August 2025. The lawsuit alleges that BellRing misrepresented sales growth as organic demand when it was actually driven by customer inventory stockpiling. Following destocking and increased competition, the company narrowed guidance and revealed weakening demand in the ready-to-drink protein market.

BRBR securities fraud class action lawsuit inventory stockpiling misrepresentation ready-to-drink protein competitive pressure stock decline
Sentiment note

Company faces securities fraud allegations for misrepresenting sales drivers, stock dropped 33% in August 2025 due to inventory destocking and increased competition, and management failed to disclose material competitive pressures affecting demand.

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal